These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1229 related articles for article (PubMed ID: 23537132)

  • 1. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S4MPLE--sampler for multiple protein-ligand entities: simultaneous docking of several entities.
    Hoffer L; Horvath D
    J Chem Inf Model; 2013 Jan; 53(1):88-102. PubMed ID: 23215156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An extensive and diverse set of molecular overlays for the validation of pharmacophore programs.
    Giangreco I; Cosgrove DA; Packer MJ
    J Chem Inf Model; 2013 Apr; 53(4):852-66. PubMed ID: 23565904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
    J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment informatics and computational fragment-based drug design: an overview and update.
    Sheng C; Zhang W
    Med Res Rev; 2013 May; 33(3):554-98. PubMed ID: 22430881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAOMInext - Synthetically feasible fragment growing in a structure-based design context.
    Sommer K; Flachsenberg F; Rarey M
    Eur J Med Chem; 2019 Feb; 163():747-762. PubMed ID: 30576905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
    Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
    J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear scoring functions for similarity-based ligand docking and binding affinity prediction.
    Brylinski M
    J Chem Inf Model; 2013 Nov; 53(11):3097-112. PubMed ID: 24171431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel strategy for three-dimensional fragment-based lead discovery.
    Yuan H; Lu T; Ran T; Liu H; Lu S; Tai W; Leng Y; Zhang W; Wang J; Chen Y
    J Chem Inf Model; 2011 Apr; 51(4):959-74. PubMed ID: 21438547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational approach to de novo discovery of fragment binding for novel protein states.
    Konteatis ZD; Klon AE; Zou J; Meshkat S
    Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal strategies for virtual screening of induced-fit and flexible target in the 2015 D3R Grand Challenge.
    Ye Z; Baumgartner MP; Wingert BM; Camacho CJ
    J Comput Aided Mol Des; 2016 Sep; 30(9):695-706. PubMed ID: 27573981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S4MPLE--Sampler for Multiple Protein-Ligand Entities: Methodology and Rigid-Site Docking Benchmarking.
    Hoffer L; Chira C; Marcou G; Varnek A; Horvath D
    Molecules; 2015 May; 20(5):8997-9028. PubMed ID: 25996209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based virtual screening of MT2 melatonin receptor: influence of template choice and structural refinement.
    Pala D; Beuming T; Sherman W; Lodola A; Rivara S; Mor M
    J Chem Inf Model; 2013 Apr; 53(4):821-35. PubMed ID: 23541165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical assessment of docking programs and scoring functions.
    Warren GL; Andrews CW; Capelli AM; Clarke B; LaLonde J; Lambert MH; Lindvall M; Nevins N; Semus SF; Senger S; Tedesco G; Wall ID; Woolven JM; Peishoff CE; Head MS
    J Med Chem; 2006 Oct; 49(20):5912-31. PubMed ID: 17004707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico fragment-mapping method: a new tool for fragment-based/structure-based drug discovery.
    Yamaotsu N; Hirono S
    J Comput Aided Mol Des; 2018 Nov; 32(11):1229-1245. PubMed ID: 30196523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
    Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
    J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead finder: an approach to improve accuracy of protein-ligand docking, binding energy estimation, and virtual screening.
    Stroganov OV; Novikov FN; Stroylov VS; Kulkov V; Chilov GG
    J Chem Inf Model; 2008 Dec; 48(12):2371-85. PubMed ID: 19007114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based fragment hopping for lead optimization using predocked fragment database.
    Lin FY; Tseng YJ
    J Chem Inf Model; 2011 Jul; 51(7):1703-15. PubMed ID: 21627327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large scale free energy calculations for blind predictions of protein-ligand binding: the D3R Grand Challenge 2015.
    Deng N; Flynn WF; Xia J; Vijayan RS; Zhang B; He P; Mentes A; Gallicchio E; Levy RM
    J Comput Aided Mol Des; 2016 Sep; 30(9):743-751. PubMed ID: 27562018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.